Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Polycythemia vera: new clinicopathologic perspectives.

Ming Cao1, Randall J Olsen, Youli Zu

  • 1Department of Pathology, The Methodist Hospital, Houston, Tex 77030, USA.

Archives of Pathology & Laboratory Medicine
|August 2, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prediction of inflammatory bowel disease recurrence risk based on multi-omics integration and machine learning models.

Computational biology and chemistry·2026
Same author

Seal whisker-inspired fully printed MEMS flow sensor via micron-scale soft material additive manufacturing.

Microsystems & nanoengineering·2026
Same author

The Role of Different Thoughts in Tacit Coordination and Its Malleability by Interventions.

Journal of cognition·2026
Same author

Propofol Attenuates Brain Ischemic Injury Through the Cannabinoid Type 1 (CB1) Receptor.

Cureus·2026
Same author

Gene Contribution of Streptococcus dysgalactiae Subspecies equisimilis, an Emerging Pathogen, to Experimental Primate Necrotizing Myositis.

The American journal of pathology·2026
Same author

Green, Formaldehyde-Free Bio-Adhesive from Soybean Meal and Laccase-Oxidized Tannin via Quinone-Amine Crosslinking.

Polymers·2026

Polycythemia vera (PV) is a myeloproliferative neoplasm. The JAK2V617F gene mutation is key to understanding PV pathogenesis and improving patient management.

Area of Science:

  • Hematology
  • Oncology
  • Molecular Biology

Background:

  • Polycythemia vera (PV) is a chronic myeloproliferative neoplasm.
  • Characterized by erythroid-dominant proliferation and bone marrow dysfunction.
  • Clinical manifestations include hemorrhage, thrombosis, and increased red cell mass.

Purpose of the Study:

  • Review recent and historical literature on Polycythemia vera.
  • Emphasize modern diagnostic criteria and emerging molecular findings.
  • Discuss the JAK2V617F gene mutation's role in PV.

Main Methods:

  • Comprehensive literature review.
  • Indexed in PubMed and referenced medical texts.

Main Results:

Related Experiment Videos

  • Modified criteria have clarified PV diagnosis.
  • The JAK2V617F mutation is present in a majority of PV patients.
  • JAK2V617F has potential diagnostic and prognostic value.

    • Conclusions:

    • Updated diagnostic criteria enhance PV identification.
    • Further research on JAK2V617F may improve PV understanding and management.
    • JAK2V617F is crucial for advancing Polycythemia vera medical care.